Claude AI Adds Biotech Pharvaris (PHVS) and AI Chipmaker Micron Technology (MU) to Portfolio, Both Also Hedge Fund Favorites
Claude AI recently added Pharvaris NV (NASDAQ: PHVS) with a 4% position and Micron Technology Inc (NASDAQ: MU) with a 6% position to its simulated portfolio. Pharvaris, a biotech company, has a key drug trial for hereditary angioedema with results due before September 30. Micron Technology, an AI chipmaker, is seen by Claude AI as having approximately 14% upside over the next year. Both stocks are also favored by hedge funds, with Pharvaris seeing steady sentiment and Micron Technology showing strong institutional interest from 154 funds as of Q1.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
XRP is testing the $1.50 resistance level, a key threshold that has capped its advances for roughly 230 days, with a break potentially leading to $1.80+
-
2
Seoul stocks rise 1.65% on chip gains despite Middle East tensions
-
3
Central Bank Digital Currency (CBDC) In-Depth Analysis: Global Progress and Impact
-
4
OKX App Download Guide: Get the World's Leading Cryptocurrency Trading Platform Application
-
5
Ankr (ANKR) Token Analysis: Web3 Infrastructure, Ecosystem Applications, and Market Dynamics
-
6
US equity futures rise, led by AI stocks; oil prices fall over 2% to around $101; US Treasury yields decline; US and Chinese officials discuss AI national security "notification mechanism."
-
7
Gamium (GMM) Token Analysis: Value, Ecosystem, and Investment Risk Assessment
-
8
BiblePay (BBP) Cryptocurrency Analysis: Charitable Mission, Technical Features, and Market Status
-
9
Binance Stock Trading Platform Adds 25 New Stocks
-
10
Commodities trader Trafigura plans to float its supertanker arm Volare Shipping in Oslo, marking the business's first IPO
Markets Today
Recommended Reading







